Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPI | P34949 | 13/20 | 0.74 |
| ▸ | PMM2 | O15305 | 10/20 | 0.74 |
| ▸ | PHOSPHO1 | Q8TCT1 | 9/20 | 0.74 |
| ▸ | G6PD | P11413 | 6/20 | 0.74 |
| ▸ | APOBEC3G | Q9HC16 | 3/20 | 0.74 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.74 |
| ▸ | MAPT | P10636 | 3/20 | 0.74 |
| ▸ | PKM | P14618 | 3/20 | 0.74 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.74 |
| ▸ | HPGD | P15428 | 2/20 | 0.74 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.74 |
| ▸ | CASP3 | P42574 | 2/20 | 0.74 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.74 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.74 |
| ▸ | RAB9A | P51151 | 2/20 | 0.66 |
| ▸ | NPC1 | O15118 | 1/20 | 0.66 |
| ▸ | TP53 | P04637 | 1/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.66 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25763324 | 0.87 | MPI (0.89) | MPIPMM2PHOSPHO1G6PDAPOBEC3G | |
| SCHEMBL30562926 | 0.85 | MPI (1.00) | MPIPMM2PHOSPHO1G6PDAPOBEC3G | |
| SCHEMBL1898397 | 0.85 | MPI (1.00) | MPIPMM2PHOSPHO1G6PDAPOBEC3G | |
| SCHEMBL30738364 | 0.84 | MPI (0.96) | MPIPMM2PHOSPHO1G6PDAPOBEC3G | |
| SCHEMBL21032975 | 0.82 | MPI (0.68) | MPIPMM2PHOSPHO1G6PDAPOBEC3G | |
| SCHEMBL26964531 | 0.80 | G6PD (0.65) | MPIPMM2PHOSPHO1G6PDAPOBEC3G | |
| SCHEMBL21033372 | 0.79 | MPI (0.74) | MPIPMM2PHOSPHO1G6PDAPOBEC3G | |
| SCHEMBL1894451 | 0.79 | MPI (1.00) | MPIPMM2PHOSPHO1G6PDAPOBEC3G | |
| SCHEMBL29910151 | 0.79 | MPI (1.00) | MPIPMM2PHOSPHO1G6PDAPOBEC3G | |
| SCHEMBL1900552 | 0.79 | MPI (0.74) | MPIPMM2PHOSPHO1G6PDAPOBEC3G |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11801262-B2 | Antibiotic compositions | THIOREDOXIN SYSTEMS AB (SE) | 2023-10-31 | — | — | US | disclosed |
| US-20210369696-A1 | Use of an N-substituted pyridyl benzisoselazolone compound | SHANGHAITECH UNIVERSITY (CN) | 2021-12-02 | — | — | US | disclosed |
| US-11013730-B1 | Composition comprising selenazol or thiazalone derivatives and silver and method of treatment therewith | THIOREDOXIN SYSTEMS AB (SE) | 2021-05-25 | — | — | US | disclosed |
| US-20200281967-A1 | Antibiotic Compositions | THIOREDOXIN SYSTEMS AB (SE) | 2020-09-10 | — | — | US | disclosed |
| US-10653717-B2 | Antibiotic compositions | THIOREDOXIN SYSTEMS AB (SE) | 2020-05-19 | — | — | US | disclosed |
| US-20190307726-A1 | PHARMACEUTICAL FORMULATIONS | MOLECULAR DEFENSES CORP (US) | 2019-10-10 | — | — | US | disclosed |
| US-20180185410-A1 | Antibiotic Compositions | THIOREDOXIN SYSTEMS AB (SE) | 2018-07-05 | — | — | US | disclosed |
| WO-2017091737-A1 | PHARMACEUTICAL FORMULATIONS | Molecular Defenses Corporation (US) | 2017-06-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190307726-A1 | PHARMACEUTICAL FORMULATIONS | GSS, GSR, MGST3 | MPI 2231/4885PMM2 4390/4885PHOSPHO1 3253/4885 |
| US-20200281967-A1 | Antibiotic Compositions | MRPL21, RPS5, MRPS35 | MPI 750/4885PMM2 2715/4885PHOSPHO1 329/4885 |
| US-20180185410-A1 | Antibiotic Compositions | MRPL21, RPS5, MRPS35 | MPI 750/4885PMM2 2715/4885PHOSPHO1 329/4885 |
| US-11013730-B1 | Composition comprising selenazol or thiazalone derivatives and silver and method of treatment therewith | SELENOI, TST, SCLY | MPI 1930/4885PMM2 4644/4885PHOSPHO1 2693/4885 |
| US-10653717-B2 | Antibiotic compositions | MRPL21, RPS5, MRPS35 | MPI 750/4885PMM2 2715/4885PHOSPHO1 329/4885 |
| US-20210369696-A1 | Use of an N-substituted pyridyl benzisoselazolone compound | SARS1, CTSL, ACE2 | MPI 691/4885PMM2 1066/4885PHOSPHO1 3333/4885 |
| US-11801262-B2 | Antibiotic compositions | MRPL21, RPS5, MRPS35 | MPI 750/4885PMM2 2715/4885PHOSPHO1 329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.